Neuronetics Inc
NASDAQ:STIM
Balance Sheet
Balance Sheet Decomposition
Neuronetics Inc
Neuronetics Inc
Balance Sheet
Neuronetics Inc
| Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & Cash Equivalents |
17
|
29
|
105
|
76
|
49
|
94
|
70
|
60
|
18
|
|
| Cash Equivalents |
17
|
29
|
105
|
76
|
49
|
94
|
70
|
60
|
18
|
|
| Total Receivables |
4
|
4
|
6
|
7
|
9
|
10
|
15
|
19
|
24
|
|
| Accounts Receivables |
4
|
4
|
6
|
7
|
7
|
8
|
14
|
16
|
23
|
|
| Other Receivables |
0
|
0
|
0
|
1
|
2
|
2
|
2
|
3
|
1
|
|
| Inventory |
2
|
3
|
2
|
3
|
4
|
7
|
9
|
8
|
4
|
|
| Other Current Assets |
1
|
1
|
2
|
3
|
3
|
5
|
4
|
7
|
11
|
|
| Total Current Assets |
23
|
37
|
115
|
89
|
65
|
115
|
99
|
94
|
58
|
|
| PP&E Net |
2
|
1
|
1
|
5
|
5
|
5
|
5
|
5
|
33
|
|
| PP&E Gross |
2
|
1
|
1
|
5
|
5
|
5
|
5
|
5
|
33
|
|
| Accumulated Depreciation |
2
|
2
|
2
|
2
|
2
|
3
|
3
|
3
|
3
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
20
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
19
|
|
| Note Receivable |
0
|
0
|
0
|
2
|
2
|
12
|
2
|
4
|
0
|
|
| Other Long-Term Assets |
0
|
1
|
1
|
5
|
6
|
9
|
11
|
13
|
11
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
19
|
|
| Total Assets |
25
N/A
|
39
+57%
|
117
+201%
|
100
-14%
|
79
-21%
|
141
+79%
|
117
-17%
|
116
-1%
|
141
+22%
|
|
| Liabilities | ||||||||||
| Accounts Payable |
2
|
3
|
4
|
5
|
4
|
4
|
2
|
5
|
11
|
|
| Accrued Liabilities |
6
|
8
|
7
|
9
|
7
|
8
|
15
|
12
|
16
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
5
|
0
|
0
|
11
|
0
|
0
|
13
|
0
|
0
|
|
| Other Current Liabilities |
1
|
2
|
3
|
3
|
3
|
4
|
3
|
3
|
4
|
|
| Total Current Liabilities |
13
|
12
|
14
|
28
|
14
|
16
|
33
|
20
|
31
|
|
| Long-Term Debt |
16
|
30
|
30
|
20
|
35
|
35
|
23
|
59
|
55
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
|
| Other Liabilities |
0
|
2
|
2
|
5
|
5
|
5
|
4
|
3
|
23
|
|
| Total Liabilities |
30
N/A
|
45
+50%
|
46
+3%
|
52
+14%
|
53
+2%
|
56
+5%
|
60
+7%
|
82
+37%
|
113
+39%
|
|
| Equity | ||||||||||
| Common Stock |
172
|
187
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Retained Earnings |
181
|
197
|
221
|
250
|
278
|
309
|
346
|
376
|
420
|
|
| Additional Paid In Capital |
4
|
4
|
292
|
298
|
303
|
394
|
403
|
410
|
447
|
|
| Total Equity |
5
N/A
|
6
-15%
|
71
N/A
|
48
-33%
|
26
-47%
|
85
+234%
|
57
-33%
|
34
-40%
|
28
-19%
|
|
| Total Liabilities & Equity |
25
N/A
|
39
+57%
|
117
+201%
|
100
-14%
|
79
-21%
|
141
+79%
|
117
-17%
|
116
-1%
|
141
+22%
|
|
| Shares Outstanding | ||||||||||
| Common Shares Outstanding |
16
|
16
|
18
|
19
|
19
|
26
|
27
|
29
|
56
|
|